The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis
- PMID: 16384756
- DOI: 10.1016/j.jaad.2005.10.006
The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis
Abstract
Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds ratio [95% confidence interval] vs placebo 2.30 [1.26-4.19]). Alefacept provided incremental efficacy over 5 successive 12-week treatment courses.
Comment in
-
On multiple courses of alefacept.J Am Acad Dermatol. 2006 Nov;55(5):916-7. doi: 10.1016/j.jaad.2006.04.075. J Am Acad Dermatol. 2006. PMID: 17052512 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical